Plenary Sessions-19/04/2020

Sunday, April 19th, 2020

8:30 – 10:45

Plenary Session 5: Bench to Bedside: New insights Into Hemostasis and Cancer

Chairs: PM Sandset (Norway), TBA

PL17 - Genetic and epigenetic regulators of single cell coagulomes in brain tumors

J Rak (Canada)

PL18 - Coagulation signaling and cancer immuno-therapy

W Ruf (Germany)

PL19 - Heparanase-revisited
Y Nadir (Israel)

PL20 - Mouse model of thrombosis and Cancer

C Dubois (France)

PL21 - Thrombin and fibrin-driven inflammation in cancer development

J Palumbo (USA)

Selected Abstract

 10:45 – 11:45

Debate: Incidental VTE: To treat or not to treat?

Chairs: S Siragusa (Italy), TBA

YES: M Di Nisio (Italy)

NO: M Carrier (Canada) 

11:45 - 12:45


12:45 – 15:00

Plenary Session 6: Evolving Data for Treatment of VTE in cancer

Chairs: TBA

PL22 - Anticoagulation in Cancer Patients: advantages and disadvantages

AJ Munoz (Spain)

PL23 - VTE management: emerging insights from the GARFIELD VTE registry

AJ Kakkar (UK)

PL24 - Treatment of VTE in cancer patients: from clinical trials to real life

G Agnelli (Italy)

PL25 - VTE in Palliative Care Patients: What do we know?

S Noble (UK) 

Selected Abstract

15:00 - 15:15

Concluding Remarks